currently investigational receiving drug eligible patients drugs excluded therapy participation 
treatments agents concurrent anti use cancer experimental investigational study days 
agents anti receiving cancer currently patients eligible investigational study entry 
years chemotherapy cancer ages prior treatment completion entry post patients 
month entry investigational therapy study prior patients treatment antitumor neoplastic